NCT02355535 2020-09-24Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 1Vanquish Oncology, Inc.Phase 1 Completed48 enrolled
NCT02402062 2020-07-27A Study to Assess the Safety and the Efficacy of the Combination of TH-302 and Sunitinib in Neuroendocrine Pancreatic TumoursGrupo Espanol de Tumores NeuroendocrinosPhase 2 Completed17 enrolled 55 charts